Literature DB >> 29708117

Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?

Servet Bölükbas1, Michael Eberlein2.   

Abstract

Entities:  

Year:  2018        PMID： 29708117      PMCID： PMC5906295          DOI： 10.21037/jtd.2018.01.171

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  29 in total

1.  Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

Authors:  E G Butchart; T Ashcroft; W C Barnsley; M P Holden
Journal:  Thorax       Date:  1976-02       Impact factor: 9.139

2.  Thoracic shaping technique to avoid residual space after extended pleurectomy/decortication.

Authors:  Servet Bölükbas; Michael Eberlein; Joachim Schirren
Journal:  Eur J Cardiothorac Surg       Date:  2013-03-13       Impact factor: 4.191

3.  Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.

Authors:  Joseph S Friedberg; Melissa J Culligan; Rosemarie Mick; James Stevenson; Stephen M Hahn; Daniel Sterman; Salman Punekar; Eli Glatstein; Keith Cengel
Journal:  Ann Thorac Surg       Date:  2012-05       Impact factor: 4.330

4.  Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.

Authors:  Hasan Fevzi Batirel; Muzaffer Metintas; Hale Basak Caglar; Guntulu Ak; Perran Fulden Yumuk; Bedrettin Yildizeli; Mustafa Yuksel
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-09       Impact factor: 5.209

5.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

6.  Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).

Authors:  Gianpiero Fasola; Ornella Belvedere; Marianna Aita; Tina Zanin; Alessandro Follador; Paolo Cassetti; Stefano Meduri; Vincenzo De Pangher; Giusto Pignata; Valentina Rosolen; Fabio Barbone; Francesco Grossi
Journal:  Oncologist       Date:  2007-10

7.  The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.

Authors:  Annabel J Sharkey; Sara Tenconi; Apostolos Nakas; David A Waller
Journal:  Eur J Cardiothorac Surg       Date:  2015-12-03       Impact factor: 4.191

8.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

9.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316

10.  Germline BAP1 mutations predispose to malignant mesothelioma.

Authors:  Joseph R Testa; Mitchell Cheung; Jianming Pei; Jennifer E Below; Yinfei Tan; Eleonora Sementino; Nancy J Cox; A Umran Dogan; Harvey I Pass; Sandra Trusa; Mary Hesdorffer; Masaki Nasu; Amy Powers; Zeyana Rivera; Sabahattin Comertpay; Mika Tanji; Giovanni Gaudino; Haining Yang; Michele Carbone
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.